Combined radiation therapy and surgery for carcinoma of the supraglottis and pyriform sinus.
Combined radiation therapy and surgery for carcinoma of the supraglottis and pyriform sinus.
复制标题
声门上癌和梨状窦癌的联合放射治疗和手术。
DOI:
10.1016/0002-9610(72)90084-0
复制
发表时间:
1972
期刊:
影响因子:
--
通讯作者:
D. Miller
中科院分区:
文献类型:
--
作者:
C. C. Wang;M. Schulz;D. Miller
Following a review of the most recently accepted TNM system for glottic carcinoma and for supraglottic carcinoma as recently reported out by the American Joint Committee for Cancer Staging, a review of our work with glottic carcinoma and with supraglottic carcinoma is now presented. It was felt that T‐3 and T‐4 glottic carcinoma simulated T‐3 and T‐4 supraglottic carcinoma, although the latter is more likely to have cervical metastasis.Conclusions of our work using 5,500 rads pre‐operatively for supraglottic carcinoma resulted in a 90 percent three‐year cure rate for T‐1 lesions, 79 percent cure rate for T‐2 lesions, 63 percent cure rate for T‐3 lesions and a 33 percent cure rate for T‐4 lesions. On the basis of our pathological studies and a follow‐up on the patients the conclusion was reached that T‐1, N‐0 or T‐2, N‐0 supraglottic carcinoma should be treated with radical radiation therapy with curative objective. For the T‐3 lesions with border line radiocurability a trial course of radiotherapy should be attempted. If the tumor shows satisfactory regression to a dose level of 4,500 rads of radiation therapy it should be continued to a curative dose level, and surgery should be reserved for radiation failures. On the other hand, if the tumor response to radiation is poor and if the tumor is large and extensive or deeply ulcerated as in T‐3 and T‐4 lesions which are often associated with lymph node metastasis, a planned combined approach of radiation and surgery is advised.